Clinical Trial Update: Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating microbiota transfer therapy in adults with Autism Spectrum Disorder and gastrointestinal disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Gastrointestinal Disorder

Drugs mentioned

• Microbiota Transfer Therapy

Snippet

Sponsor: Arizona State University | Conditions: Autism Spectrum Disorder, Gastrointestinal Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING